281 related articles for article (PubMed ID: 18826383)
1. SAA and PLTP activity in plasma of periodontal patients before and after full-mouth tooth extraction.
Vuletic S; Taylor BA; Tofler GH; Chait A; Marcovina SM; Schenck K; Albers JJ
Oral Dis; 2008 Sep; 14(6):514-9. PubMed ID: 18826383
[TBL] [Abstract][Full Text] [Related]
2. Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance.
Matuliene G; Pjetursson BE; Salvi GE; Schmidlin K; Brägger U; Zwahlen M; Lang NP
J Clin Periodontol; 2008 Aug; 35(8):685-95. PubMed ID: 18549447
[TBL] [Abstract][Full Text] [Related]
3. Persistently raised C-reactive protein levels are associated with advanced periodontal disease.
Linden GJ; McClean K; Young I; Evans A; Kee F
J Clin Periodontol; 2008 Sep; 35(9):741-7. PubMed ID: 18647204
[TBL] [Abstract][Full Text] [Related]
4. High-sensitivity serum C-reactive protein levels in subjects with or without myocardial infarction or periodontitis.
Persson GR; Pettersson T; Ohlsson O; Renvert S
J Clin Periodontol; 2005 Mar; 32(3):219-24. PubMed ID: 15766362
[TBL] [Abstract][Full Text] [Related]
5. Systemic inflammation following non-surgical and surgical periodontal therapy.
Graziani F; Cei S; Tonetti M; Paolantonio M; Serio R; Sammartino G; Gabriele M; D'Aiuto F
J Clin Periodontol; 2010 Sep; 37(9):848-54. PubMed ID: 20546085
[TBL] [Abstract][Full Text] [Related]
6. Plasma and crevicular fluid osteopontin levels in periodontal health and disease.
Sharma CG; Pradeep AR
J Periodontal Res; 2007 Oct; 42(5):450-5. PubMed ID: 17760823
[TBL] [Abstract][Full Text] [Related]
7. Periodontal disease is associated with higher levels of C-reactive protein in non-diabetic, non-smoking acute myocardial infarction patients.
Kodovazenitis G; Pitsavos C; Papadimitriou L; Deliargyris EN; Vrotsos I; Stefanadis C; Madianos PN
J Dent; 2011 Dec; 39(12):849-54. PubMed ID: 21946158
[TBL] [Abstract][Full Text] [Related]
8. Salivary antioxidants in patients with type 1 or 2 diabetes and inflammatory periodontal disease: a case-control study.
Gümüş P; Buduneli N; Cetinkalp S; Hawkins SI; Renaud D; Kinane DF; Scott DA
J Periodontol; 2009 Sep; 80(9):1440-6. PubMed ID: 19722794
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid transfer protein in hemodialysis patients.
Schlitt A; Heine GH; Jiang XC; Messow M; Blankenberg S; Rupprecht HJ; Ulrich C; Buerke M; Werdan K; Lackner KJ; Köhler H; Girndt M
Am J Nephrol; 2007; 27(2):138-43. PubMed ID: 17308375
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.
Dullaart RP; de Vries R; Dallinga-Thie GM; Sluiter WJ; van Tol A
Clin Endocrinol (Oxf); 2008 Mar; 68(3):375-81. PubMed ID: 17877759
[TBL] [Abstract][Full Text] [Related]
11. Association between serum calcium and periodontal disease progression in non-institutionalized elderly.
Amarasena N; Yoshihara A; Hirotomi T; Takano N; Miyazaki H
Gerodontology; 2008 Dec; 25(4):245-50. PubMed ID: 18380783
[TBL] [Abstract][Full Text] [Related]
12. Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus.
Oomen PH; van Tol A; Hattori H; Smit AJ; Scheek LM; Dullaart RP
Diabet Med; 2005 Jun; 22(6):768-74. PubMed ID: 15910630
[TBL] [Abstract][Full Text] [Related]
13. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
[TBL] [Abstract][Full Text] [Related]
14. Early decreases in plasma lipid transfer proteins during weight reduction.
Tzotzas T; Dumont L; Triantos A; Karamouzis M; Constantinidis T; Lagrost L
Obesity (Silver Spring); 2006 Jun; 14(6):1038-45. PubMed ID: 16861609
[TBL] [Abstract][Full Text] [Related]
15. High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease.
Schlitt A; Bickel C; Thumma P; Blankenberg S; Rupprecht HJ; Meyer J; Jiang XC
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1857-62. PubMed ID: 12947020
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in the treatment of generalized aggressive periodontitis: II. Effects of smoking on initial outcome.
Hughes FJ; Syed M; Koshy B; Bostanci N; McKay IJ; Curtis MA; Marcenes W; Croucher RE
J Clin Periodontol; 2006 Sep; 33(9):671-6. PubMed ID: 16856898
[TBL] [Abstract][Full Text] [Related]
17. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.
Tan KC; Shiu SW; Wong Y; Wong WK; Tam S
Diabetes Metab Res Rev; 2006; 22(4):307-12. PubMed ID: 16389649
[TBL] [Abstract][Full Text] [Related]
18. The effect of initial treatment of periodontitis on systemic markers of inflammation and cardiovascular risk: a randomized controlled trial.
Taylor B; Tofler G; Morel-Kopp MC; Carey H; Carter T; Elliott M; Dailey C; Villata L; Ward C; Woodward M; Schenck K
Eur J Oral Sci; 2010 Aug; 118(4):350-6. PubMed ID: 20662907
[TBL] [Abstract][Full Text] [Related]
19. Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia.
Herrera JA; Parra B; Herrera E; Botero JE; Arce RM; Contreras A; López-Jaramillo P
J Hypertens; 2007 Jul; 25(7):1459-64. PubMed ID: 17563569
[TBL] [Abstract][Full Text] [Related]
20. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment.
Vogt L; Laverman GD; van Tol A; Groen AK; Navis G; Dullaart RP
Nephrol Dial Transplant; 2006 Jan; 21(1):101-6. PubMed ID: 16141462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
